Recurrence of primary biliary cirrhosis after liver transplantation following FK506-based immunosuppression

Philip Wong(Indiana University – Purdue University Indianapolis), Roger Williams(MRC Laboratory of Molecular Biology), B Portmann(King's College Hospital), John G. o'Grady(King's College Hospital), John Devlin(King's College Hospital), Kai Chah Tan(King's College Hospital), John E. Hegarty(St. Vincent's University Hospital)
Journal of Hepatology
January 1, 1993
10.1016/s0168-8278(05)80206-5
Cited by 74

Related Papers

Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
|Hepatology|2014|2k
A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling
|Cell|2006|1.2k
Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases
|Nature Chemical Biology|2008|440
Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis
|Gastroenterology|1985|411
The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors
|Nature Chemical Biology|2010|292